Evidence map›Paper›PMID 41726168›Full record

ArticleDigital biomarkers

Toward a Speech-Based Model of Premanifest Huntington's Disease Progression Using Deep Neural Networks.

Luis A Sierra, Japleen Kaur, Namhee Kwon, Vinod Subramanian, Raymond Brueckner, Nate Blaylock, Henry O'Connell, Samuel A Frank, Jody Corey-Bloom, Simon Laganiere

Abstract read
In one paragraph

Article in Digital biomarkers. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Luis A SierraDepartment of Neurology, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Japleen KaurDepartment of Neurosciences, University of California San Diego, School of Medicine, San Diego, CA, USA.
Namhee KwonCanary Speech, Inc., Provo, UT, USA.
Vinod SubramanianCanary Speech, Inc., Provo, UT, USA.
Raymond BruecknerCanary Speech, Inc., Provo, UT, USA.
Nate BlaylockCanary Speech, Inc., Provo, UT, USA.
Henry O'ConnellCanary Speech, Inc., Provo, UT, USA.
Samuel A FrankDepartment of Neurology, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Jody Corey-BloomDepartment of Neurosciences, University of California San Diego, School of Medicine, San Diego, CA, USA.
Simon LaganiereDepartment of Neurology, Beth Israel Deaconess Medical Center, Boston, MA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Huntington's disease (HD) is a progressive neurodegenerative disorder characterized by motor, cognitive, and psychiatric decline. The Unified Huntington's Disease Rating Scale Total Motor Score (UHDRS-TMS) is standard for staging manifest disease, but is relatively insensitive to subtle premanifest changes. Speech abnormalities are emerging as candidate digital biomarkers; however, reliably separating premanifest HD (preHD) from healthy controls remains challenging. Here, we assess the feasibility of a speech-only approach by training and comparing multiple classifiers across diverse feature sets and structured tasks to determine whether speech alone can discriminate preHD from controls. Methods: Speech samples were collected from 94 individuals with HD (38 premanifest, 56 manifest) and 36 controls using a standardized six-task protocol administered via tablet. From these recordings, 188 lexical and prosodic features were automatically extracted. We trained 4 machine learning classifiers: random forest, support vector machine, XGBoost, and deep neural networks (DNNs), within 10-fold cross-validation using three feature configurations: (1) all tasks (188 features), (2) the top 30 ANOVA-ranked features, and (3) 22 features from the Caterpillar passage alone. Results: Traditional classifiers showed limited accuracy. A DNN using only the Caterpillar task achieved 81% unweighted accuracy for classifying preHD versus controls. Accuracy increased to 83% for prodromal HD and 87% when all HD participants were compared to controls. Adding features from additional tasks did not improve performance. Conclusion: A brief, structured speech task combined with deep learning enabled accurate classification of preHD. These findings support speech analysis as a scalable, objective tool for early disease detection and monitoring.

Indexed as

Deep learningDigital phenotypingHuntington’s diseaseMachine learningPremanifest Huntington’s diseaseSpeech biomarkers

Identifiers

PMID41726168
PMCPMC12923257

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.